Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the target of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 33,500 shares, a growth of 225.2% from the November 15th total of 10,300 shares. Based on an average daily volume of 4,900 shares, the short-interest ratio is currently 6.8 days.

Institutional Trading of Fidelity Disruptive Medicine ETF

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Jane Street Group LLC boosted its position in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 200.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 61,342 shares of the company’s stock after buying an additional 40,924 shares during the quarter. Jane Street Group LLC owned approximately 2.92% of Fidelity Disruptive Medicine ETF worth $1,613,000 as of its most recent filing with the Securities & Exchange Commission.

Fidelity Disruptive Medicine ETF Stock Performance

FMED stock traded down $0.08 during trading on Friday, hitting $25.57. 3,424 shares of the company traded hands, compared to its average volume of 5,423. The company has a 50-day moving average of $25.91 and a 200-day moving average of $25.24. Fidelity Disruptive Medicine ETF has a 1 year low of $22.82 and a 1 year high of $26.68. The firm has a market capitalization of $53.70 million, a PE ratio of 35.73 and a beta of 0.94.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.